0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Felodipine Tablets Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-9N13413
Home | Market Reports | Health| Pharmacy
Global Felodipine Tablets Market Research Report 2023
BUY CHAPTERS

Global Felodipine Tablets Market Research Report 2025

Code: QYRE-Auto-9N13413
Report
February 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

The global market for Felodipine Tablets was valued at US$ 259 million in the year 2024 and is projected to reach a revised size of US$ 350 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Felodipine Tablets Market

Felodipine Tablets Market

Felodipine is a calcium channel blocker. It works by affecting the movement of calcium into the cells of the heart and blood vessels. Felodipine relaxes blood vessels and increases the supply of blood and oxygen to the heart, which reduces the workload. 
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Felodipine Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Felodipine Tablets.
The Felodipine Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Felodipine Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Felodipine Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Felodipine Tablets Market Report

Report Metric Details
Report Name Felodipine Tablets Market
Accounted market size in year US$ 259 million
Forecasted market size in 2031 US$ 350 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Ordinary Tablet
  • Sustained Release Tablet
Segment by Application
  • Treat High Blood Pressure
  • Relieve Angina
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Astrazeneca, Sandoz, SHANXI KANGBO BIOLOGICAL PRODUCT, Changzhou Siyao Pharmaceutical, Lianhuan Pharma, Sihuan Pharma, CR Double Crane, Xiehe Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Felodipine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Felodipine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Felodipine Tablets Market growing?

Ans: The Felodipine Tablets Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Felodipine Tablets Market size in 2031?

Ans: The Felodipine Tablets Market size in 2031 will be US$ 350 million.

Who are the main players in the Felodipine Tablets Market report?

Ans: The main players in the Felodipine Tablets Market are Astrazeneca, Sandoz, SHANXI KANGBO BIOLOGICAL PRODUCT, Changzhou Siyao Pharmaceutical, Lianhuan Pharma, Sihuan Pharma, CR Double Crane, Xiehe Pharma

What are the Application segmentation covered in the Felodipine Tablets Market report?

Ans: The Applications covered in the Felodipine Tablets Market report are Treat High Blood Pressure, Relieve Angina, Others

What are the Type segmentation covered in the Felodipine Tablets Market report?

Ans: The Types covered in the Felodipine Tablets Market report are Ordinary Tablet, Sustained Release Tablet

Recommended Reports

Cardiovascular Drugs

Heart Treatments

Chronic Disease Drugs

1 Felodipine Tablets Market Overview
1.1 Product Definition
1.2 Felodipine Tablets by Type
1.2.1 Global Felodipine Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Ordinary Tablet
1.2.3 Sustained Release Tablet
1.3 Felodipine Tablets by Application
1.3.1 Global Felodipine Tablets Market Value by Application (2024 VS 2031)
1.3.2 Treat High Blood Pressure
1.3.3 Relieve Angina
1.3.4 Others
1.4 Global Felodipine Tablets Market Size Estimates and Forecasts
1.4.1 Global Felodipine Tablets Revenue 2020-2031
1.4.2 Global Felodipine Tablets Sales 2020-2031
1.4.3 Global Felodipine Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Felodipine Tablets Market Competition by Manufacturers
2.1 Global Felodipine Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Felodipine Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Felodipine Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Felodipine Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Felodipine Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Felodipine Tablets, Product Type & Application
2.7 Global Key Manufacturers of Felodipine Tablets, Date of Enter into This Industry
2.8 Global Felodipine Tablets Market Competitive Situation and Trends
2.8.1 Global Felodipine Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Felodipine Tablets Players Market Share by Revenue
2.8.3 Global Felodipine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Felodipine Tablets Market Scenario by Region
3.1 Global Felodipine Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Felodipine Tablets Sales by Region: 2020-2031
3.2.1 Global Felodipine Tablets Sales by Region: 2020-2025
3.2.2 Global Felodipine Tablets Sales by Region: 2026-2031
3.3 Global Felodipine Tablets Revenue by Region: 2020-2031
3.3.1 Global Felodipine Tablets Revenue by Region: 2020-2025
3.3.2 Global Felodipine Tablets Revenue by Region: 2026-2031
3.4 North America Felodipine Tablets Market Facts & Figures by Country
3.4.1 North America Felodipine Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Felodipine Tablets Sales by Country (2020-2031)
3.4.3 North America Felodipine Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Felodipine Tablets Market Facts & Figures by Country
3.5.1 Europe Felodipine Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Felodipine Tablets Sales by Country (2020-2031)
3.5.3 Europe Felodipine Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Felodipine Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Felodipine Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Felodipine Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Felodipine Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Felodipine Tablets Market Facts & Figures by Country
3.7.1 Latin America Felodipine Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Felodipine Tablets Sales by Country (2020-2031)
3.7.3 Latin America Felodipine Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Felodipine Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Felodipine Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Felodipine Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Felodipine Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Felodipine Tablets Sales by Type (2020-2031)
4.1.1 Global Felodipine Tablets Sales by Type (2020-2025)
4.1.2 Global Felodipine Tablets Sales by Type (2026-2031)
4.1.3 Global Felodipine Tablets Sales Market Share by Type (2020-2031)
4.2 Global Felodipine Tablets Revenue by Type (2020-2031)
4.2.1 Global Felodipine Tablets Revenue by Type (2020-2025)
4.2.2 Global Felodipine Tablets Revenue by Type (2026-2031)
4.2.3 Global Felodipine Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Felodipine Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Felodipine Tablets Sales by Application (2020-2031)
5.1.1 Global Felodipine Tablets Sales by Application (2020-2025)
5.1.2 Global Felodipine Tablets Sales by Application (2026-2031)
5.1.3 Global Felodipine Tablets Sales Market Share by Application (2020-2031)
5.2 Global Felodipine Tablets Revenue by Application (2020-2031)
5.2.1 Global Felodipine Tablets Revenue by Application (2020-2025)
5.2.2 Global Felodipine Tablets Revenue by Application (2026-2031)
5.2.3 Global Felodipine Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Felodipine Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Astrazeneca
6.1.1 Astrazeneca Company Information
6.1.2 Astrazeneca Description and Business Overview
6.1.3 Astrazeneca Felodipine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Astrazeneca Felodipine Tablets Product Portfolio
6.1.5 Astrazeneca Recent Developments/Updates
6.2 Sandoz
6.2.1 Sandoz Company Information
6.2.2 Sandoz Description and Business Overview
6.2.3 Sandoz Felodipine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sandoz Felodipine Tablets Product Portfolio
6.2.5 Sandoz Recent Developments/Updates
6.3 SHANXI KANGBO BIOLOGICAL PRODUCT
6.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Information
6.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Description and Business Overview
6.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Product Portfolio
6.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
6.4 Changzhou Siyao Pharmaceutical
6.4.1 Changzhou Siyao Pharmaceutical Company Information
6.4.2 Changzhou Siyao Pharmaceutical Description and Business Overview
6.4.3 Changzhou Siyao Pharmaceutical Felodipine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Changzhou Siyao Pharmaceutical Felodipine Tablets Product Portfolio
6.4.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates
6.5 Lianhuan Pharma
6.5.1 Lianhuan Pharma Company Information
6.5.2 Lianhuan Pharma Description and Business Overview
6.5.3 Lianhuan Pharma Felodipine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lianhuan Pharma Felodipine Tablets Product Portfolio
6.5.5 Lianhuan Pharma Recent Developments/Updates
6.6 Sihuan Pharma
6.6.1 Sihuan Pharma Company Information
6.6.2 Sihuan Pharma Description and Business Overview
6.6.3 Sihuan Pharma Felodipine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sihuan Pharma Felodipine Tablets Product Portfolio
6.6.5 Sihuan Pharma Recent Developments/Updates
6.7 CR Double Crane
6.7.1 CR Double Crane Company Information
6.7.2 CR Double Crane Description and Business Overview
6.7.3 CR Double Crane Felodipine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CR Double Crane Felodipine Tablets Product Portfolio
6.7.5 CR Double Crane Recent Developments/Updates
6.8 Xiehe Pharma
6.8.1 Xiehe Pharma Company Information
6.8.2 Xiehe Pharma Description and Business Overview
6.8.3 Xiehe Pharma Felodipine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Xiehe Pharma Felodipine Tablets Product Portfolio
6.8.5 Xiehe Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Felodipine Tablets Industry Chain Analysis
7.2 Felodipine Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Felodipine Tablets Production Mode & Process Analysis
7.4 Felodipine Tablets Sales and Marketing
7.4.1 Felodipine Tablets Sales Channels
7.4.2 Felodipine Tablets Distributors
7.5 Felodipine Tablets Customer Analysis
8 Felodipine Tablets Market Dynamics
8.1 Felodipine Tablets Industry Trends
8.2 Felodipine Tablets Market Drivers
8.3 Felodipine Tablets Market Challenges
8.4 Felodipine Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Felodipine Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Felodipine Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Felodipine Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Felodipine Tablets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Felodipine Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Felodipine Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Felodipine Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Felodipine Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Felodipine Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Felodipine Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Felodipine Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Felodipine Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Felodipine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Felodipine Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Felodipine Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Felodipine Tablets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Felodipine Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Felodipine Tablets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Felodipine Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Felodipine Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Felodipine Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Felodipine Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Felodipine Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Felodipine Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Felodipine Tablets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Felodipine Tablets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Felodipine Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Felodipine Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Felodipine Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Felodipine Tablets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Felodipine Tablets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Felodipine Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Felodipine Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Felodipine Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Felodipine Tablets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Felodipine Tablets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Felodipine Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Felodipine Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Felodipine Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Felodipine Tablets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Felodipine Tablets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Felodipine Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Felodipine Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Felodipine Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Felodipine Tablets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Felodipine Tablets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Felodipine Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Felodipine Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Felodipine Tablets Sales (K Units) by Type (2020-2025)
 Table 51. Global Felodipine Tablets Sales (K Units) by Type (2026-2031)
 Table 52. Global Felodipine Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Felodipine Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Felodipine Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Felodipine Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Felodipine Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Felodipine Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Felodipine Tablets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Felodipine Tablets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Felodipine Tablets Sales (K Units) by Application (2020-2025)
 Table 61. Global Felodipine Tablets Sales (K Units) by Application (2026-2031)
 Table 62. Global Felodipine Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Felodipine Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Felodipine Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Felodipine Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Felodipine Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Felodipine Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Felodipine Tablets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Felodipine Tablets Price (US$/Unit) by Application (2026-2031)
 Table 70. Astrazeneca Company Information
 Table 71. Astrazeneca Description and Business Overview
 Table 72. Astrazeneca Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Astrazeneca Felodipine Tablets Product
 Table 74. Astrazeneca Recent Developments/Updates
 Table 75. Sandoz Company Information
 Table 76. Sandoz Description and Business Overview
 Table 77. Sandoz Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sandoz Felodipine Tablets Product
 Table 79. Sandoz Recent Developments/Updates
 Table 80. SHANXI KANGBO BIOLOGICAL PRODUCT Company Information
 Table 81. SHANXI KANGBO BIOLOGICAL PRODUCT Description and Business Overview
 Table 82. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Product
 Table 84. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
 Table 85. Changzhou Siyao Pharmaceutical Company Information
 Table 86. Changzhou Siyao Pharmaceutical Description and Business Overview
 Table 87. Changzhou Siyao Pharmaceutical Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Changzhou Siyao Pharmaceutical Felodipine Tablets Product
 Table 89. Changzhou Siyao Pharmaceutical Recent Developments/Updates
 Table 90. Lianhuan Pharma Company Information
 Table 91. Lianhuan Pharma Description and Business Overview
 Table 92. Lianhuan Pharma Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Lianhuan Pharma Felodipine Tablets Product
 Table 94. Lianhuan Pharma Recent Developments/Updates
 Table 95. Sihuan Pharma Company Information
 Table 96. Sihuan Pharma Description and Business Overview
 Table 97. Sihuan Pharma Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sihuan Pharma Felodipine Tablets Product
 Table 99. Sihuan Pharma Recent Developments/Updates
 Table 100. CR Double Crane Company Information
 Table 101. CR Double Crane Description and Business Overview
 Table 102. CR Double Crane Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CR Double Crane Felodipine Tablets Product
 Table 104. CR Double Crane Recent Developments/Updates
 Table 105. Xiehe Pharma Company Information
 Table 106. Xiehe Pharma Description and Business Overview
 Table 107. Xiehe Pharma Felodipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Xiehe Pharma Felodipine Tablets Product
 Table 109. Xiehe Pharma Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Felodipine Tablets Distributors List
 Table 113. Felodipine Tablets Customers List
 Table 114. Felodipine Tablets Market Trends
 Table 115. Felodipine Tablets Market Drivers
 Table 116. Felodipine Tablets Market Challenges
 Table 117. Felodipine Tablets Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Felodipine Tablets
 Figure 2. Global Felodipine Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Felodipine Tablets Market Share by Type: 2024 & 2031
 Figure 4. Ordinary Tablet Product Picture
 Figure 5. Sustained Release Tablet Product Picture
 Figure 6. Global Felodipine Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Felodipine Tablets Market Share by Application: 2024 & 2031
 Figure 8. Treat High Blood Pressure
 Figure 9. Relieve Angina
 Figure 10. Others
 Figure 11. Global Felodipine Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Felodipine Tablets Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Felodipine Tablets Sales (2020-2031) & (K Units)
 Figure 14. Global Felodipine Tablets Average Price (US$/Unit) & (2020-2031)
 Figure 15. Felodipine Tablets Report Years Considered
 Figure 16. Felodipine Tablets Sales Share by Manufacturers in 2024
 Figure 17. Global Felodipine Tablets Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Felodipine Tablets Players: Market Share by Revenue in Felodipine Tablets in 2024
 Figure 19. Felodipine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Felodipine Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Felodipine Tablets Sales Market Share by Country (2020-2031)
 Figure 22. North America Felodipine Tablets Revenue Market Share by Country (2020-2031)
 Figure 23. United States Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Felodipine Tablets Sales Market Share by Country (2020-2031)
 Figure 26. Europe Felodipine Tablets Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Felodipine Tablets Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Felodipine Tablets Revenue Market Share by Region (2020-2031)
 Figure 34. China Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Felodipine Tablets Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Felodipine Tablets Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Felodipine Tablets Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Felodipine Tablets Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Felodipine Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Felodipine Tablets by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Felodipine Tablets by Type (2020-2031)
 Figure 55. Global Felodipine Tablets Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Felodipine Tablets by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Felodipine Tablets by Application (2020-2031)
 Figure 58. Global Felodipine Tablets Price (US$/Unit) by Application (2020-2031)
 Figure 59. Felodipine Tablets Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart